2 Startups Awarded $175,000 Each to Further Develop Cancer Treatment Technologies

Alnair Therapeutics and Riptide Therapeutics have been awarded investments from the George Shultz Innovation Fund to further develop their cancer treatment technologies. Both will receive $175,000 investments from the Fund.…

Digital Health, Therapeutics Startups Selected for George Shultz Innovation Fund Finals

The Polsky Center for Entrepreneurship and Innovation at the University of Chicago has announced the companies selected for the 2022 fall cohort of the George Shultz Innovation Fund. Managed by…

Three Teams Selected for Spring 2021 George Shultz Innovation Fund

The Polsky Center for Entrepreneurship and Innovation at the University of Chicago has announced the companies selected for the 2021 spring cohort of the George Shultz Innovation Fund. The program…

Polsky Center Hires Christine Karslake, MBA ’95, to Manage University of Chicago’s Portfolio of Science and Technology Ventures

The Polsky Center for Entrepreneurship and Innovation at the University of Chicago has hired Christine Karslake, PhD, MBA ’95, as Managing Director of Polsky Science Ventures. In this newly created…

NanoPattern Technologies, ReAx Biotechnologies Receive $150,000 Each to Commercialize Research

The Polsky Center for Entrepreneurship and Innovation at the University of Chicago has chosen two companies – NanoPattern Technologies and ReAx Biotechnologies – to invest in as part of the…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept